Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other
companies in this sector in UNITED STATES :
sales of $23.36 billion
of which 22%
of which 78%
was Bioscience), and
of which 100%
Gilead Sciences reported sales of $22.45 billion
December of 2019.
a very small
increase of 1.5%
versus 2018, when the company's sales were $22.13 billion.
Despite this increase, sales are still
below the level achieved in 2017, when Gilead Sciences
reported sales of $26.11 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Gilead Sciences had sales
of $24.89 billion.